April 3 (Reuters) - Integragen SA ALINT.PA :
* 2020 OUTLOOK: CASH AVAILABLE WILL BE USED TO FINANCE
OPERATIONAL
AND INVESTMENT REQUIREMENTS
* FY NET LOSS EUR 0.3 MILLION VERSUS LOSS OF EUR 1.1 MILLION
YEAR
AGO
* FY OPERATING LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 1.2
MILLION
YEAR AGO
* NET CASH AND CASH EQUIVALENTS AT THE END OF 2019 AMOUNTED
TO
€2.7 MILLION COMPARED TO €3.9 MILLION AT THE END OF 2018
* OUTLOOK 2020 : THE SEQOIA PROJECT IS EXPECTED TO GENERATE
A
MINIMUM TURNOVER OF € 2,700 K, AND THEREFORE ANTICIPATES, AT
THIS STAGE, A STRONG GROWTH IN TURNOVER FOR THE FINANCIAL YEAR
* ON CORONAVIRUS: THE TEAM BASED AT THE EVRY LABORATORY AND
THE
ONE BASED AT THE PASTEUR INSTITUTE CONTINUE THEIR ACTIVITIES
* IMPLEMENTATION OF BUSINESS CONTINUITY MEASURES DURING THE
COVID-19 PANDEMIC
* 2020 OUTLOOK: ALSO EXPECTS INCREASED SALES OF SEQUENCING
DATA
INTERPRETATION SOFTWARE (SIRIUS™, MERCURY™ET GALILEO™) IN SAAS
(SOFTWARE AS A SERVICE) MODE
* THE STABILITY OF THE COMPANY'S BUSINESS MODEL SHOULD
ENABLE
INTEGRAGEN TO RESUME ITS ACTIVITY AND RECOVER MOST OF THE LACK
OF ACTIVITY RECORDED DURING THE PANDEMIC
* CONTRACT WITH THE INSTITUT PASTEUR HAS BEEN EXTENDED UNTIL
DECEMBER 2021, BASED ON AN INCREASED LEVEL OF PERFORMANC
Source text for Eikon: ID:nNDLc5Y5qk
Further company coverage: ALINT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))